A Vancouver-based therapeutics company has received regulatory approval to begin the second Phase II trial…
mjoyJanuary 5, 2023
Cells have the remarkable ability to respond to stress. During stress conditions, the RNA and…
mjoyJanuary 4, 2023
STEMCELL Technologies is proud to announce its President and CEO, Dr. Allen Eaves, has been…
mjoyJanuary 4, 2023
We are pleased to congratulate Stephanie Besoiu and Petya Popova, recipients of the 2022 Zymeworks…
mjoyJanuary 4, 2023
Dr. Jiarui Ding (pictured) at UBC received NSERC funding for his project on uncovering the…
mjoyJanuary 3, 2023
AbCellera (Nasdaq: ABCL) announced today that it has entered into a multi-year, multi-target strategic collaboration with AbbVie Inc.…
mjoyJanuary 3, 2023
Dr. Kim Nguyen Chi, a respected prostate cancer researcher and oncologist, will take over as head of B.C.…
sciencecityJune 21, 2019
Last week, Dr. Dermot Kelleher, Dean of the Faculty of Medicine at the University of…
sciencecityJune 21, 2019
This week, the Government of Canada announced the next phase of funding for the Canadian…
sciencecityJune 20, 2019
Reducing a specific protein in the fat cells of mice not only prevents onset of…
sciencecityJune 19, 2019
The ability to genetically modify a cell is a powerful tool. Genetically modified cells have advanced our…
sciencecityJune 19, 2019
When Queen Elizabeth II (QEII) Diamond Jubilee Scholar Fredrick Omondi graduates in June, he will…
sciencecityJune 18, 2019
AbCellera, a leader in therapeutic antibody discovery from natural immune systems, today announced it has…
sciencecityJune 14, 2019
Dr. Liisa Galea, PhD, is a Professor in the Department of Psychology, and a member of…
sciencecityJune 13, 2019
